142 related articles for article (PubMed ID: 38191150)
1. Construction of a 12-gene prognostic model for colorectal cancer based on heat shock protein-related genes.
Tong Q; Zhou J
Int J Hyperthermia; 2024; 41(1):2290913. PubMed ID: 38191150
[TBL] [Abstract][Full Text] [Related]
2. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Yu S; Chen M; Xu L; Mao E; Sun S
Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
[TBL] [Abstract][Full Text] [Related]
3. Establishment and verification of prognostic model and ceRNA network analysis for colorectal cancer liver metastasis.
Zhang X; Wu T; Zhou J; Chen X; Dong C; Guo Z; Yang R; Liang R; Feng Q; Hu R; Li Y; Ding R
BMC Med Genomics; 2023 May; 16(1):99. PubMed ID: 37161577
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
Huang Y; Gong P; Su L; Zhang M
Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
6. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
Liang X; Cheng Z; Chen X; Li J
Front Genet; 2022; 13():955424. PubMed ID: 36046241
[No Abstract] [Full Text] [Related]
7. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
Wang H; Wang W; Wang Z; Li X
Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
[TBL] [Abstract][Full Text] [Related]
8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
10. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
11. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
15. Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.
Liu W; Luo X; Zhang Z; Chen Y; Dai Y; Deng J; Yang C; Liu H
Cancer Immunol Immunother; 2024 Mar; 73(4):69. PubMed ID: 38430268
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
17. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.
Zhu S; Zhao Q; Fan Y; Tang C
BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825
[TBL] [Abstract][Full Text] [Related]
18. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
Zhao X; Lin J
Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
[TBL] [Abstract][Full Text] [Related]
19. Prediction of prognosis and immune landscape in cervical cancer based on heat shock protein-related genes.
Wang M; Li Z
Int J Hyperthermia; 2023; 40(1):2259140. PubMed ID: 37750398
[No Abstract] [Full Text] [Related]
20. Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
Zhao J; Quan J; Chen W; Xie X
Eur J Med Res; 2023 Nov; 28(1):511. PubMed ID: 37964339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]